4//SEC Filing
Kern Ralph Dr. 4
Accession 0001104659-20-033203
CIK 0001137883other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:01 PM ET
Size
5.9 KB
Accession
0001104659-20-033203
Insider Transaction Report
Form 4
Kern Ralph Dr.
COO and Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-03-09+80,000→ 80,000 totalExercise: $7.33From: 2020-03-09Exp: 2030-03-09→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]Option becomes vested and exercisable as to 25% of the number of shares on each of the first four anniversaries of the grant date until fully vested and exercisable on the fourth anniversary of the grant date.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC.
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0001699684
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:01 PM ET
- Size
- 5.9 KB